logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Careggi University Hospital

+39055794111
aouc@aou-careggi.toscana.it
Source: Site record.
https://www.aou-careggi.toscana.it

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Careggi University Hospital (Azienda Ospedaliero-Universitaria Careggi), located at Largo Giovanni Alessandro Brambilla, 3, 50134 Firenze, Italy, is the largest public polyclinic and teaching hospital in Florence and a primary medical hub for the Tuscany region. Spread across a massive 78-hectare campus at the foot of the Careggi hill, this highly ranked institution serves as a major center for advanced healthcare, cutting-edge medical research, and professional training in close partnership with the University of Florence.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. Otolaryngologist
Source: Trial-derived.
99Total Trials
Source: Trial-derived.
28Recruiting Trials
Source: Trial-derived.
36Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
169Unique Conditions
Source: Trial-derived.
109Unique Sponsors

Conditions

Source: Trial-derived. Acute Myeloid Leukemia (3)Source: Trial-derived. Atrial Fibrillation (2)Source: Trial-derived. Breast Cancer (2)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (2)Source: Trial-derived. Covid19 (2)Source: Trial-derived. Crohn's Disease (2)Source: Trial-derived. Cutaneous T Cell Lymphoma (2)Source: Trial-derived. Cutaneous T-Cell Lymphoma/Mycosis Fungoides (2)

Sponsors

Source: Trial-derived. Fondazione Italiana Linfomi - ETS (14)Source: Trial-derived. Azienda Ospedaliero-Universitaria Careggi (7)Source: Trial-derived. University of Florence (6)Source: Trial-derived. Gruppo Italiano Malattie EMatologiche dell'Adulto (5)Source: Trial-derived. Merck Sharp & Dohme LLC (4)Source: Trial-derived. FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS (3)Source: Trial-derived. Gilead Sciences (3)Source: Trial-derived. Hoffmann-La Roche (3)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. PET-CT
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome (eDiary) system
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Nasal endoscopy
Source: AI-inferred. Nasal peak inspiratory flow measurement
Source: AI-inferred. Stereotactic body radiotherapy (SBRT)
Source: AI-inferred. Tumour response imaging (modality not specified)
Source: AI-inferred. Visual acuity testing (Snellen chart)